用于肿瘤药物发现的人类急性淋巴细胞白血病异种移植物的产生

Q2 Pharmacology, Toxicology and Pharmaceutics
Linda Holmfeldt, Charles G. Mullighan
{"title":"用于肿瘤药物发现的人类急性淋巴细胞白血病异种移植物的产生","authors":"Linda Holmfeldt,&nbsp;Charles G. Mullighan","doi":"10.1002/0471141755.ph1432s68","DOIUrl":null,"url":null,"abstract":"<p>The establishment of reproducible mouse models of acute lymphoblastic leukemia (ALL) is necessary to provide in vivo therapeutic test systems that recapitulate human ALL, and for amplification of limited amounts of primary tumor material. A popular assay is the primary xenograft model that utilizes immunocompromised mice. The protocol includes injection of primary patient tumor specimens into mice with subsequent serial passaging of the tumors by retransplants of cells harvested from the mouse bone marrow and spleen. The tumors generated are then used for genomic profiling, ex vivo compound testing, mechanistic studies and retransplantation. Detailed in this unit are procedures for the establishment and maintenance of primary ALL xenograft panels for use in basic research and translational studies. © 2015 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":10871,"journal":{"name":"Current Protocols in Pharmacology","volume":"68 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/0471141755.ph1432s68","citationCount":"6","resultStr":"{\"title\":\"Generation of Human Acute Lymphoblastic Leukemia Xenografts for Use in Oncology Drug Discovery\",\"authors\":\"Linda Holmfeldt,&nbsp;Charles G. Mullighan\",\"doi\":\"10.1002/0471141755.ph1432s68\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The establishment of reproducible mouse models of acute lymphoblastic leukemia (ALL) is necessary to provide in vivo therapeutic test systems that recapitulate human ALL, and for amplification of limited amounts of primary tumor material. A popular assay is the primary xenograft model that utilizes immunocompromised mice. The protocol includes injection of primary patient tumor specimens into mice with subsequent serial passaging of the tumors by retransplants of cells harvested from the mouse bone marrow and spleen. The tumors generated are then used for genomic profiling, ex vivo compound testing, mechanistic studies and retransplantation. Detailed in this unit are procedures for the establishment and maintenance of primary ALL xenograft panels for use in basic research and translational studies. © 2015 by John Wiley &amp; Sons, Inc.</p>\",\"PeriodicalId\":10871,\"journal\":{\"name\":\"Current Protocols in Pharmacology\",\"volume\":\"68 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-03-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/0471141755.ph1432s68\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Protocols in Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/0471141755.ph1432s68\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Protocols in Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/0471141755.ph1432s68","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 6

摘要

建立可重复的急性淋巴细胞白血病(ALL)小鼠模型对于提供概括人类ALL的体内治疗试验系统以及扩增有限数量的原发肿瘤物质是必要的。一种流行的试验是利用免疫功能低下的小鼠进行原发异种移植模型。该方案包括将原发患者肿瘤标本注射到小鼠体内,随后通过从小鼠骨髓和脾脏中获取的细胞再移植,对肿瘤进行连续传代。产生的肿瘤随后被用于基因组分析、体外化合物测试、机制研究和再移植。本单元详细介绍了用于基础研究和转化研究的原发性ALL异种移植板的建立和维护程序。©2015 by John Wiley &儿子,Inc。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Generation of Human Acute Lymphoblastic Leukemia Xenografts for Use in Oncology Drug Discovery

Generation of Human Acute Lymphoblastic Leukemia Xenografts for Use in Oncology Drug Discovery

Generation of Human Acute Lymphoblastic Leukemia Xenografts for Use in Oncology Drug Discovery

Generation of Human Acute Lymphoblastic Leukemia Xenografts for Use in Oncology Drug Discovery

The establishment of reproducible mouse models of acute lymphoblastic leukemia (ALL) is necessary to provide in vivo therapeutic test systems that recapitulate human ALL, and for amplification of limited amounts of primary tumor material. A popular assay is the primary xenograft model that utilizes immunocompromised mice. The protocol includes injection of primary patient tumor specimens into mice with subsequent serial passaging of the tumors by retransplants of cells harvested from the mouse bone marrow and spleen. The tumors generated are then used for genomic profiling, ex vivo compound testing, mechanistic studies and retransplantation. Detailed in this unit are procedures for the establishment and maintenance of primary ALL xenograft panels for use in basic research and translational studies. © 2015 by John Wiley & Sons, Inc.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Protocols in Pharmacology
Current Protocols in Pharmacology Pharmacology, Toxicology and Pharmaceutics-Pharmacology
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信